S11.1 Stratification of systemic lupus erythematosus (SLE) patients based on the molecular patterns of mouse models

• A Buttgereit,
• M Morell,
• ME Alarcón-Riquelme,
• F McDonald,
• M Rivas-Torrubia,
• Z Makowska,
• J Kageyama,
• P Cytometry Consortium,
• R Lesche,
• G Barturen-Briñas

Affiliations

A Buttgereit

1German Rheumatism Research Centre Berlin (DRFZ), Berlin, Germany

M Morell

Centre de Genética Médica i Molecular - IRO, Hospital Duran i Reynals, Barcelona, Spain

ME Alarcón-Riquelme

1Centro de Genómica e Investigación Oncológica (GENYO), Pfizer-Universidad de Granada-Junta de Andalucía, Granada, Spain

F McDonald

executive officer, EBMT

M Rivas-Torrubia

1GENYO. Centre for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government PTS Granada ~ Spain

Z Makowska

2Pharmaceuticals Division, Bayer Pharma Aktiengesellschaft ~ Berlin ~ Germany

J Kageyama

2Pharmaceuticals Division, Bayer Pharma Aktiengesellschaft ~ Berlin ~ Germany

P Cytometry Consortium

1GENYO. Centre for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government PTS Granada ~ Spain

R Lesche

2Pharmaceuticals Division, Bayer Pharma Aktiengesellschaft ~ Berlin ~ Germany

G Barturen-Briñas

1GENYO. Centre for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government PTS Granada ~ Spain